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Purpose: To report three cases of posterior vasculitis associated with subacute giant cell 
arteritis (GCA).
Methods: Three patients with decreased vision underwent complete ophthalmologic 
examination and ﬂ uorescein angiography.
Results: All patients presented posterior vasculitis. Patient 1 had an erythrocyte sedimentation 
rate (ESR) of 38 mm/hr and a C-reactive protein (CRP) of 28mg/L. Patient 2 and 3 had an ESR 
of 104 and 95 mm/hr and a CRP of 42 and 195 mg/L accordingly. Diagnosis was established by 
temporal artery biopsy. Resolution was observed after systemic prednisolone therapy.
Conclusion: GCA should be suspected when posterior vasculitis and relatively high ESR and 
CRP are present.
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Introduction
Giant cell arteritis (GCA), known as temporal arteritis or Horton’s disease is a systemic 
vasculitis of unknown etiology and pathogenesis, which typically occurs in patients 
older than 60 years.1 The typical ophthalmic symptom is sudden vision loss in one 
or both eyes. In the majority of cases the diagnosis of GCA is based on a positive 
temporal artery biopsy result. In approximately 10% of patients, in whom the biopsy 
is falsely negative the diagnosis can be based on the clinical features.
Posterior vasculitis associated with low-grade uveitis is uncommon as a presenting 
feature of GCA.
We present three cases of GCA who had developed posterior vasculitis. In all cases 
GCA could be proven by temporal artery biopsy.
Case reports
Patient 1
A 70-year-old man was referred to the Jules Gonin Eye Hospital for cataract extraction. 
Four months before, he complained of a rapid decrease of visual acuity (VA) of OS, 
associated with violent headaches. A partial occlusion of the central artery of the retina 
of the OD was then diagnosed by his ophthalmologist.
At presentation best-corrected VA measured with a standard Snellen chart was 
found equal to 0.2 OD and light perception (LP) OS. There was a left afferent pupillary 
defect. Slit lamp examination revealed the presence of a bilateral cataract. The fundus 
examination revealed the presence of inﬂ ammatory cells in the vitreous, right disc 
edema, multiple raised creamy subretinal peripapillary lesions and narrow arterial 
vessels of the posterior pole. The ﬂ uorescein angiography revealed signs of posterior 
vasculitis with ﬂ uffy, white perivascular inﬁ ltrates in the eye (Figure 1). Also, visual 
ﬁ elds were affected in the OD with an altitudinal defect.
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The general physical examination was essentially normal. 
Investigations revealed an erythrocyte sedimentation rate 
(ESR) of 38 mm/hr in the ﬁ rst hour and 78 mm/hr in the 
second hour along with a C-reactive protein (CRP) of 
28 mg/ml (normal value  6 mg/ml). A temporal artery 
biopsy was performed which showed evidence of GCA.
With the diagnosis of GCA, systemic steroid therapy was 
initiated. Eight months later cataract surgery was performed, 
while the patient was still treated with prednisolone 20 mg/d 
orally administered. Final best-corrected VA improved to 
0.4 in the OD.
Patient 2
An 83-year-old woman was referred to our department with 
the diagnosis of bilateral cataract and anterior synechiae of 
the OS. Nine months earlier, the patient described increased 
fatigability, bitemporal severe headaches and anorexia with a 
6-kg weight loss. Three months after the onset of symptoms, 
VA started to decrease in both eyes.
At presentation, best-corrected VA measured with 
a standard Snellen chart was 0.05 OD and 0.7 OS. No 
afferent pupillary defect was present. Ocular motility was 
normal. Goldmann visual ﬁ elds showed a superior temporal 
loss in the OD. The left visual ﬁ eld was normal. Fundus 
examination showed a swollen right optic disc. Fluorescein 
angiography revealed segmental disc hyperﬂ uorescence and 
signs of arterial vasculitis at the posterior pole with arteriolar 
attenuation, sheathing and cotton wool spots suggestive of 
arteriolar involvement (Figure 2).
Investigations revealed the presence of hypochromic 
microcytic anaemia, diverticulitis along with an ESR 
of 104 mm/hr in the ﬁ rst hour and a CRP of 42 mg/ml. 
A temporal artery biopsy specimen conﬁ rmed GCA.
Under this diagnosis, methylprednisolone 1 mg/kg/day 
was administered intravenously for three days, reducing the 
ESR from 104 to the range of 84. At discharge, the patient’s 
regimen consisted of prednisone 50 mg orally per day. Two 
weeks later, the ESR was found equal to 18 mm/hr in the ﬁ rst 
hour. Final best-corrected VA was 0.2 OD and 0.7 OS.
Patient 3
An 83-year-old man complained of rapid decrease of vision 
of the OS, diplopia and a pain in the left hemiface starting 
near the ear region with irradiation to the left temple. At that 
time, diagnosis of trigeminal neuralgia was suspected and 
investigations were focused on the temporo-mendibular 
Figure 1 Fluorescein angiography OD showing leakage from the subretinal peripapillary lesions and the optic disc with vasculitis of the posterior pole.
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articulation. Two weeks later, a visual impairment of the OS 
occurred and the patient was referred to our department for 
further investigation.
At presentation, best-corrected VA was limited to count 
ﬁ ngers for both eyes.
Fundus examination revealed the presence of pale optic 
nerve heads, narrowed arterial vessels and severe ischemia 
in both eyes. A zone of hyperﬂ uorescence was present in 
the late phase ﬂ uorescein angiogram in the OD, secondary 
to posterior vasculitis (Figure 3).
Laboratory results revealed an ESR of 95 mm/hr in the 
ﬁ rst hour and a CRP of 195 mg/ml. A temporal artery biopsy 
specimen conﬁ rmed GCA.
Under this diagnosis, intravenous treatment with 500 mg 
of methylprednisolone for three consecutive days, increased 
to 1 g for three more days was introduced. To avoid the onset 
of neovascularization a photocoagulation of the ischemic 
zones was performed. Systemic steroids were gradually 
tapered over the next few months and azathioprime was 
initiated, in order to decrease more rapidly the dose of 
steroids due to the appearance of diabetes mellitus.
At the end of the follow-up in our department, ﬁ nal 
best-corrected VA improved to 0.1 OD and 0.05 OS. 
The patient was still treated with prednisone 15 mg/day 
associated with azathioprime 150 mg/day.
Discussion
GCA is a systemic vasculitis of unknown cause, which 
involves predominantly medium-sized extracranial arteries 
of the carotid circulation and sometimes the aorta and its pri-
mary branches. It can be distinguished from other vasculities 
by the age of the patient, the new onset of localized head-
ache, a temporal artery tenderness or reduced pulsation, an 
elevated ESR, and characteristic ﬁ ndings at temporal artery 
biopsy. The rate of ophthalmic involvement is reported to 
be as high as 50% in some older series.2 A rapid partial or 
complete visual loss is the most common and the most seri-
ous ophthalmic complication of GCA. Rates of vision loss as 
high as 35% to 50% have been reported.3,4 Generally, vision 
loss from GCA is permanent. An elevated ESR and elevated 
levels of other acute-phase reactants such as ﬁ brinogen, CRP, 
and haptoglobin are present in the vast majority of patients 
(patient 2 and 3).
This well known acute evolution of GCA, which involves 
typical cranial and ophthalmic signs and symptoms, should 
not occult the possibility of subacute or chronic forms of 
Figure 2 Fluorescein angiography OD showing partial disc edema and fi ne vasculitis of the posterior pole.
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Horton’s disease. A normal blood count and ESR do not 
exclude the diagnosis (patient 1).5,6
In our case series, all three patients had a subacute 
evolution of the disease of one month duration or more before 
the diagnosis and the onset of steroid therapy. Two (patient 
2 and 3) were investigated in internal medicine, but in the 
presence of an atypical presentation, the diagnosis of GCA 
could not be promptly established. Although patient 2 had a 
history of weight loss and violent headaches at presentation, 
the diagnosis of GCA was not considered because many 
patients do not seek medical attention for headache or 
constitutional symptoms, and thus GCA remains undiagnosed 
until catastrophic vision loss occurs.
In patient 3, the presence of sigmoidal diverticulitis was 
suspected to be at the origin, because sometimes clinicians 
elicit a more speciﬁ c complaint such as tenderness or jaw 
claudication in order to pose the diagnosis of GCA.
In conclusion, because GCA is a potentially blinding 
disease and its early diagnose is the key to preventing 
blindness, it is important to recognize its early ocular 
manifestations.7 Posterior vasculitis as a presenting 
feature is uncommon and to the best of our knowledge 
there is one case report where the presenting feature was 
subacute panuveitis as a presenting feature of GCA.8 The 
ﬂ uorescein angiogram showed retinal vasculitis and there 
was no wedge shaped alteration suggestive of choroidal 
ischemia.9
In our case series, all three patients presented posterior 
vasculitis. Anterior synechiae (patient 3) can also be observed 
in cases of Horton’s disease. A mild type of Horton’s disease 
should also be kept in mind in cases presenting a chronic 
evolution with loss of weight, headache, or visual symptoms. 
In all of our cases of Horton’s disease, the diagnosis could 
undoubtedly be established with a positive biopsy of the 
temporal artery.
Conclusion
We describe a case series of three patients in which 
GCA offers a possible explanation for the clinical picture 
of posterior vasculitis. Therefore, Horton’s disease 
must absolutely be ruled out in cases of chronic ocular 
inﬂ ammation in order to avoid an irreversible severe vision 
impairment or vision loss.
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Figure 3 Fluorescein angiography OD reveals the hyperfl uorescence of the optic disc due to vasculitis.
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